Business Practice

Does a medicine’s price consistently track with its benefits and value? Not in the US, according to a study.

A new not-for-profit company will manufacture important generics in the US

The UK’s Centre for Process Innovation targets easier manufacturing of nanoformulated medicines.

Which biopharma positions are hardest to fill? What skills are most in demand? And what can companies do to ensure they discover and nurture talent?

First-of-its-kind Parkinson’s trial, Brexit woes, and a vaccine scandal in China… What’s new for pharma in business?

Do methods that compare newly approved drugs with those already on the market help cut healthcare costs?

Most, but not all, UK pharma companies are on track to keep their medicines on the European market by March, 2019.

Here, James speaks with Christophe Le Ret from Umicore.

Here, James speaks with Michel Lagarde from Thermo Fischer Scientific (Patheon).

Here, James speaks with Tony van Bijleveld from Thermo Fischer Scientific (Patheon).